Cargando…
Role of trypsin and protease-activated receptor-2 in ovarian cancer
Proteases have been implicated in the tumorigenesis and aggressiveness of a variety of cancer types. In fact, proteases have proven to be very clinically useful as tumor biomarkers in the blood of patients. Proteases are typically involved in complex systems of substrates, activators, and inhibitors...
Autores principales: | Kim, Kyu Kwang, Turner, Rachael, Khazan, Negar, Kodza, Arif, Jones, Aaron, Singh, Rakesh K., Moore, Richard G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197761/ https://www.ncbi.nlm.nih.gov/pubmed/32365084 http://dx.doi.org/10.1371/journal.pone.0232253 |
Ejemplares similares
-
Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines
por: Kim, Kyu Kwang, et al.
Publicado: (2020) -
Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer
por: Rowswell-Turner, Rachael B., et al.
Publicado: (2019) -
Replacement of Trypsin by Proteases for Medical Applications
por: Matinfar, Alireza, et al.
Publicado: (2022) -
Proteomics Using Protease Alternatives to Trypsin
Benefits from Sequential Digestion with Trypsin
por: Dau, Therese, et al.
Publicado: (2020) -
Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases
por: Carroll, Emma L., et al.
Publicado: (2021)